Lincoln Pharma Q1 FY27 consolidated net profit jumped 30.90% YoY to ₹36.23 Cr, with total income up 19.02% to ₹201.55 Cr.

Lincoln Pharmaceuticals LimitedLINCOLN · Filed with the exchange

Board proposed an 18% (₹1.80/share) dividend for FY26. Company targets ₹1000 Cr revenue in 3 years. #LincolnPharma #Earnings

No comments yet. Be the first.

More from Lincoln Pharmaceuticals Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.